Welcome to the IQ Therapeutics website. IQ Therapeutics is a biopharmaceutical company developing fully human antibodies for the prevention and treatment of healthcare threats.
Saturday, 28 January 2012
Welcome to IQ Therapeutics
about
IQ Therapeutics is an innovative company contributing to healthcare and excelling in immune-based applications. The company is a spin off from IQ Corporation.
IQ Therapeutics has developed a proprietary technology for the generation of fully human antibodies, duplicating the antibodies generated by vaccinated or immunized donors. It is our philosophy that the most physiological origin for antibodies to be applied as therapeutic agent inside a human body is the human body itself. The human immune response is the basis for our technology and therefore we have termed it "Cloning the Human Response".
The objective is to apply the CHR technology for the generation of protective antibodies which can serve as passive immunization to protect humans against infectious diseases and oncology, thus providing "instant immunity".
Cloning the Human Response is applied for proprietary programs to build a pipeline of potential novel antibody based drugs. Moreover, the technology is offered as a service for third parties.
Subscribe to our RSS Feed 